PRMT5 Inhibition Enhances Elimination of FLT3-ITD AML Stem Cells in Combination with TKI Treatment

Autor: Kumar, Harish *, Dhir, Aditi *, Paterson, Andrew J. *, Anderson, Nick R, Qiu, Shaowei *, Zhao, Xinyang, Lu, Rui, Bhatia, Ravi
Zdroj: In Blood 15 November 2022 140 Supplement 1:3073-3074
Databáze: ScienceDirect